CIK: 0001917529 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value ($000): $521,764 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 4,896,462 | $134,016 | 25.7% | $58.25 | -37.4% | Common Stock | 501575104 |
| IRON | Disc Medicine, Inc. | 2,384,456 | $118,364 | 22.7% | $48.39 | +14.9% | Common Stock | 254604101 |
| DYN | Dyne Therapeutics, Inc. | 9,130,465 | $95,505 | 18.3% | $13.88 | +3.1% | Common Stock | 26818M108 |
| DAWN | Day One Biopharmaceuticals, Inc. | 6,430,257 | $50,992 | 9.8% | $19.68 | -45.3% | Common Stock | 23954D109 |
| SION | Sionna Therapeutics, Inc. | 3,694,020 | $38,639 | 7.4% | $16.34 | 0.0% | Common Stock | 829401108 |
| — | Third Harmonic Bio, Inc. | 10,402,286 | $36,096 | 6.9% | $18.97 | — | Common Stock | 88427A107 |
| KRRO | Korro Bio, Inc. | 1,137,149 | $19,798 | 3.8% | $33.30 | -11.0% | Common Stock | 500946108 |
| — | Vigil Neuroscience, Inc. | 5,836,874 | $10,390 | 2.0% | $7.03 | — | Common Stock | 92673K108 |
| — | Ikena Oncology, Inc. | 5,018,178 | $6,423 | 1.2% | $12.54 | — | Common Stock | 45175G108 |
| — | Aerovate Therapeutics, Inc. | 1,799,232 | $4,516 | 0.9% | $11.88 | — | Common Stock | 008064107 |
| QTTB | Q32 Bio, Inc. | 2,092,106 | $3,452 | 0.7% | $13.78 | -80.5% | Common Stock | 746964105 |
| — | Generation Bio, Co. | 8,279,484 | $3,353 | 0.6% | $7.08 | — | Common Stock | 37148K100 |
| SPRO | Spero Therapeutics, Inc. | 305,255 | $220 | 0.0% | $15.88 | -94.7% | Common Stock | 84833T103 |